{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:37Z","timestamp":1786119457748,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/cco.0b013e328330c669","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T01:47:43Z","timestamp":1267062463000},"page":"559-565","source":"Crossref","is-referenced-by-count":31,"title":["Brain damage from anticancer treatments in adults"],"prefix":"10.1097","volume":"21","author":[{"given":"Damien","family":"Ricard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Taillia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1634\/theoncologist.2008-0130","article-title":"Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy","volume":"13","author":"Dietrich","year":"2008","journal-title":"Oncologist"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10014-008-0233-9","article-title":"Pathological review of late cerebral radionecrosis","volume":"25","author":"Yoshii","year":"2008","journal-title":"Brain Tumor Pathol"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3171\/JNS\/2008\/109\/12\/S17","article-title":"Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme","volume":"109","author":"Smith","year":"2008","journal-title":"J Neurosurg"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2008.06.1919","article-title":"Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas","volume":"73","author":"Schwer","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","journal-title":"Lancet Oncol"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cncr.23562","article-title":"Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide","volume":"113","author":"Taal","year":"2008","journal-title":"Cancer"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients","volume":"26","author":"Brandes","year":"2008","journal-title":"J Clin Oncol"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-006-9241-y","article-title":"Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma","volume":"82","author":"Chamberlain","year":"2007","journal-title":"J Neurooncol"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-009-9801-z","article-title":"Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis","volume":"94","author":"Torcuator","year":"2009","journal-title":"J Neurooncol"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","article-title":"Effect of bevacizumab on radiation necrosis of the brain","volume":"67","author":"Gonzalez","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-007-9474-4","article-title":"Longitudinal cognitive follow-up in low grade gliomas","volume":"86","author":"Correa","year":"2008","journal-title":"J Neurooncol"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1634\/theoncologist.2008-0236","article-title":"Primary CNS lymphoma in immunocompetent patients","volume":"14","author":"Sierra del Rio","year":"2009","journal-title":"Oncologist"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-008-9716-0","article-title":"Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy","volume":"91","author":"Correa","year":"2009","journal-title":"J Neurooncol"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/annonc\/mdn628","article-title":"High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study","volume":"20","author":"Illerhaus","year":"2009","journal-title":"Ann Oncol"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2007.09.059","article-title":"Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis","volume":"71","author":"Li","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2007.08.020","article-title":"Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study","volume":"70","author":"Nagesh","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1200\/JCO.2007.12.5468","article-title":"Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial","volume":"25","author":"P\u00f6ttgen","year":"2007","journal-title":"J Clin Oncol"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.23222","article-title":"Neurocognitive function in patients with small-cell lung cancer. Effects of prophylactic cranial irradiation","volume":"112","author":"Grosshans","year":"2008","journal-title":"Cancer"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2008.03.009","article-title":"Memory function before and after whole brain radiotherapy in patients with and without brain metastases","volume":"72","author":"Welzel","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2008.17.0746","article-title":"Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms \u2013 results of international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups","volume":"27","author":"Slotman","year":"2009","journal-title":"J Clin Oncol"},{"key":"R22-11-20210128","first-page":"574","article-title":"Cognitive function in survivors of cancer.","volume":"570-","author":"Vardy","year":"2009","journal-title":"Education Book ASCO"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/annonc\/mdm500","article-title":"Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop","volume":"19","author":"Vardy","year":"2008","journal-title":"Ann Oncol"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pon.1398","article-title":"No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy","volume":"18","author":"Mehlsen","year":"2009","journal-title":"Psychooncology"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/CCO.0b013e3282f0e224","article-title":"Chemobrain: is systemic chemotherapy neurotoxic?","volume":"19","author":"Taillibert","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"R26-11-20210128","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00381-007-0576-2","article-title":"Detection and characterization of neurotoxicitiy in cancer patients using proton MR spectroscopy","volume":"24","author":"Steffen-Smith","year":"2008","journal-title":"Childs Nerv Syst"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/cncr.23853","article-title":"Short-term effects of treatment-induced hormonal changes on cognition function in breast cancer patients","volume":"113","author":"Hermelink","year":"2008","journal-title":"Cancer"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/pon.1372","article-title":"The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer","volume":"18","author":"Mar Fan","year":"2009","journal-title":"Psychooncology"},{"key":"R29-11-20210128","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.mehy.2007.06.019","article-title":"Chemobrain \u2013 a psychotropic drug phenomenon?","volume":"70","author":"Jackson","year":"2008","journal-title":"Med Hypoth"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2007.08.004","article-title":"Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat","volume":"186","author":"Seigers","year":"2008","journal-title":"Behav Brain Res"},{"key":"R31-11-20210128","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrc2507","article-title":"Cytokines and their relationship to the symptoms and outcome of cancer","volume":"8","author":"Seruga","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R32-11-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","article-title":"Cognitive function in breast cancer patients prior to adjuvant treatment","volume":"110","author":"Ahles","year":"2008","journal-title":"Breast Cancer Res Treat"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCO.0b013e328330c669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:12:26Z","timestamp":1786039946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-200911000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e328330c669","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}